Physician profile
Aaron David Tolan
NPI 1881909596
$7,817.67
in general payments reported to CMS, 2019-2025
52 companies · $2,381 in 2025
The $2,381 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $260 · 2021: $543 · 2022: $790 · 2023: $1,807 · 2024: $1,795 · 2025: $2,381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,983.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,713.73 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Lilly USA, LLC | $829.58 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $732.46 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $689.55 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $517.07 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Glaxosmithkline, LLC. | $336.28 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Lundbeck LLC | $259.91 | 2023-2025 | Vyepti, Rexulti |
| Neurocrine Biosciences, INC. | $244.57 | 2023-2025 | Ingrezza, Ongentys |
| Otsuka America Pharmaceutical, INC. | $196.02 | 2021-2025 | Rexulti, Nuedexta |
| Eisai INC. | $189.66 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $156.66 | 2023-2025 | Gvoke Hypopen |
| Astrazeneca Pharmaceuticals LP | $150.23 | 2019-2025 | Breztri, Airsupra |
| Alexion Pharmaceuticals, INC. | $140.52 | 2024-2025 | Ultomiris |
| Neurelis, INC. | $136.88 | 2024-2025 | Valtoco |
| Acadia Pharmaceuticals INC | $128.10 | 2025 | Nuplazid |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $108.08 | 2025 | Caplyta |
| Dexcom, INC. | $103.37 | 2021-2023 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $101.26 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Argenx US, INC. | $83.00 | 2025 | Vyvgart Hytrulo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.91 | 2019-2024 | Tradjenta, Synjardy, Jardiance |
| Amgen INC. | $59.55 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $58.20 | 2022 | |
| Vanda Pharmaceuticals INC. | $49.67 | 2024-2025 | Fanapt, Hetlioz |
| Tg Therapeutics, INC. | $49.51 | 2025 | |
| Axsome Therapeutics, INC. | $48.31 | 2025 | Symbravo |
| Genzyme Corporation | $42.84 | 2025 | |
| Janssen Pharmaceuticals, INC | $42.25 | 2021-2022 | |
| Ultragenyx Pharmaceutical INC. | $41.05 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.87 | 2019 | |
| Idorsia Pharmaceuticals US INC | $32.27 | 2022-2023 | Quviviq |
| Shield Therapeutics INC | $32.06 | 2025 | |
| Merck Sharp & Dohme LLC | $32.00 | 2019-2025 | Lagevrio |
| Csl Behring | $30.30 | 2025 | Hizentra |
| Sanofi-Aventis U.S. LLC | $28.51 | 2020 | |
| Ironshore Pharmaceuticals INC. | $26.76 | 2019-2020 | |
| Averitas Pharma INC. | $26.52 | 2025 | Qutenza |
| Abbott Laboratories | $24.23 | 2020-2021 | |
| Genentech USA, INC. | $22.67 | 2025 | Ocrevus |
| Sk Life Science, INC. | $21.26 | 2025 | |
| Cranial Technologies, INC | $20.95 | 2025 | Doc Band |
| Edwards Lifesciences Corporation | $20.76 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Impel Pharmaceuticals LLC | $20.71 | 2025 | Trudhesa |
| Sanofi Pasteur INC. | $19.86 | 2019 | |
| Ucb, INC. | $19.27 | 2025 | Briviact |
| Tris Pharma INC | $18.01 | 2024 | Dyanavel Xr |
| Kyowa Kirin, INC. | $17.89 | 2023 | Nourianz |
| Neos Therapeutics, LP | $17.85 | 2019 | |
| Impel Pharmaceuticals INC. | $16.03 | 2023 | Trudhesa |
| Tactile Systems Technology INC | $15.88 | 2024 | Flexitouch Plus, Entre Plus |
| Catalyst Pharmaceuticals, INC. | $15.83 | 2023 | Firdapse |
| Radius Health, INC. | $14.52 | 2020 | |
| Phadia US INC. | $14.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Tolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.